Rockefeller University: Why a Promising Breast Cancer Drug Doesn't Work--and How to Improve It
September 11, 2024
September 11, 2024
NEW YORK, Sept. 11 (TNSres) -- Rockefeller University issued the following news:
Hopes were high a decade ago, when a new class of drugs called BET inhibitors emerged for treating blood cancers and solid tumors. Since then, however, results from numerous clinical trial have painted a much more complex picture--especially when it comes to breast cancer.
Now, a new study published in Nature Structural & Molecular Biology explains why the therapy, which continues to sh . . .
Hopes were high a decade ago, when a new class of drugs called BET inhibitors emerged for treating blood cancers and solid tumors. Since then, however, results from numerous clinical trial have painted a much more complex picture--especially when it comes to breast cancer.
Now, a new study published in Nature Structural & Molecular Biology explains why the therapy, which continues to sh . . .